Leanne M.  Kelly net worth and biography

Leanne Kelly Biography and Net Worth

Ms. Leanne Kelly is the CFO of Vallon Pharmaceuticals. She is 47 years old.

What is Leanne M. Kelly's net worth?

The estimated net worth of Leanne M. Kelly is at least $62.61 as of June 4th, 2021. Ms. Kelly owns 121 shares of Vallon Pharmaceuticals stock worth more than $63 as of April 18th. This net worth evaluation does not reflect any other assets that Ms. Kelly may own. Additionally, Ms. Kelly receives an annual salary of $328,520.00 as CFO at Vallon Pharmaceuticals. Learn More about Leanne M. Kelly's net worth.

How old is Leanne M. Kelly?

Ms. Kelly is currently 45 years old. There are 3 older executives and no younger executives at Vallon Pharmaceuticals. The oldest executive at Vallon Pharmaceuticals is Dr. Timothy M. Whitaker, Chief Medical Officer, who is 63 years old. Learn More on Leanne M. Kelly's age.

What is Leanne M. Kelly's salary?

As the CFO of Vallon Pharmaceuticals, Inc., Ms. Kelly earns $328,520.00 per year. The highest earning executive at Vallon Pharmaceuticals is Mr. David C. Baker, CEO, Pres & Director, who commands a salary of $553,550.00 per year. Learn More on Leanne M. Kelly's salary.

How do I contact Leanne M. Kelly?

The corporate mailing address for Ms. Kelly and other Vallon Pharmaceuticals executives is TWO LOGAN SQUARE 100 N. 18TH STREET SUITE 300, PHILADELPHIA PA, 19103. Vallon Pharmaceuticals can also be reached via phone at 267-607-8255 and via email at [email protected]. Learn More on Leanne M. Kelly's contact information.

Has Leanne M. Kelly been buying or selling shares of Vallon Pharmaceuticals?

Leanne M. Kelly has not been actively trading shares of Vallon Pharmaceuticals in the last ninety days. Most recently, on Friday, June 4th, Leanne M. Kelly bought 50 shares of Vallon Pharmaceuticals stock. The stock was acquired at an average cost of $122.40 per share, with a total value of $6,120.00. Following the completion of the transaction, the chief financial officer now directly owns 121 shares of the company's stock, valued at $14,810.40. Learn More on Leanne M. Kelly's trading history.

Leanne M. Kelly Insider Trading History at Vallon Pharmaceuticals

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/4/2021Buy50$122.40$6,120.00121View SEC Filing Icon  
6/2/2021Buy121$120.00$14,520.00121View SEC Filing Icon  
See Full Table

Leanne M. Kelly Buying and Selling Activity at Vallon Pharmaceuticals

This chart shows Leanne M Kelly's buying and selling at Vallon Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Vallon Pharmaceuticals Company Overview

Vallon Pharmaceuticals logo
Vallon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medications for central nervous system disorders with a focus on abuse-deterrent medications. Its lead investigational product candidate is ADAIR, an abuse-deterrent oral formulation of immediate-release dextroamphetamine for the treatment of attention-deficit/hyperactivity disorder (ADHD) and narcolepsy. The company is also developing ADMIR, an abuse deterrent formulation of methylphenidate for the treatment of ADHD. Vallon Pharmaceuticals, Inc. was incorporated in 2018 and is based in Philadelphia, Pennsylvania.
Read More

Today's Range

Now: $0.52
Low: $0.51
High: $0.53

50 Day Range

MA: $0.67
Low: $0.27
High: $2.87

2 Week Range

Now: $0.52
Low: $0.21
High: $12.92

Volume

44,128 shs

Average Volume

5,783,646 shs

Market Capitalization

$6.98 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A